Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure. 1986

G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini

Peripheral hemodynamics were studied using strain gauge plethysmography in patients with congestive heart failure after administration of ibopamine (SB-7505), the orally active 3,4-diisobutyryl ester of N-methyldopamine, a dopaminergic agonist, and of sulpiride, a specific dopaminergic antagonist. 50 mg of sulpiride were administered parenterally in 12 patients 3 h after a single oral dose of 150 mg of ibopamine. Ibopamine increased significantly resting arterial blood flow and venous capacity and decreased peripheral resistance. Sulpiride was found to significantly counteract the activity of ibopamine.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010991 Plethysmography Recording of change in the size of a part as modified by the circulation in it. Plethysmographies
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D003846 Deoxyepinephrine Sympathomimetic, vasoconstrictor agent. Deoxyadrenaline,Desoxyadrenaline,Methyldopamine,Desoxyepinephrine,Epinine
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure

Related Publications

G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini
February 1993, European heart journal,
G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini
January 1986, VASA. Zeitschrift fur Gefasskrankheiten,
G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini
January 1989, Journal of cardiovascular pharmacology,
G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini
May 1985, British journal of clinical pharmacology,
G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini
January 1987, Clinical and experimental hypertension. Part A, Theory and practice,
G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini
March 1981, Circulation,
G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini
February 1986, Arzneimittel-Forschung,
G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini
January 1986, Pharmacotherapy,
G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini
January 1989, International journal of clinical pharmacology research,
G F Musacci, and L Ansani, and T Toselli, and S Aggio, and E Baracca, and C Longhini
January 1990, Cardiology,
Copied contents to your clipboard!